Literature DB >> 2679154

Unusual sinonasal small-cell neoplasms following radiotherapy for bilateral retinoblastomas.

H F Frierson1, G W Ross, F M Stewart, S A Newman, M D Kelly.   

Abstract

Two patients developed sinonasal small-cell neoplasms that arose 22 years and 37 years, respectively, following radiotherapy for bilateral retinoblastomas. The tumors were composed of small cells with scant cytoplasm and had a few scattered Homer-Wright rosettes. Immunohistochemically, one tumor was positive for keratin (CAM 5.2 and AE1/AE3), epithelial membrane antigen, and neuron-specific enolase. The other neoplasm was immunoreactive for keratin (CAM 5.2 only) and neuron-specific enolase; it also had focal immunopositivity for S-100 protein, desmin, and muscle-specific actin. Both were negative for CEA, vimentin, melanocyte-specific antigen (HMB45), chromogranin A, synaptophysin, Leu-7, 200 kd neurofilament, and retinal S-antigen. Despite aggressive multimodal therapy, the patients died of metastatic tumor 7 months and 10 months following their initial diagnosis, respectively. Although osteosarcoma is the most frequent second cancer following bilateral retinoblastomas, some patients develop clinically aggressive sinonasal small-cell tumors that are difficult to place into conventional classifications. Both of our cases showed evidence of multidirectional differentiation; one tumor labeled with epithelial and neural markers, and the other expressed epithelial, neural, and myogenous antigens.

Entities:  

Mesh:

Year:  1989        PMID: 2679154     DOI: 10.1097/00000478-198911000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  2 in total

1.  Neuroendocrine Tumors of the Head and Neck: A Selected Review with Emphasis on Terminology.

Authors:  Stacey E. Mills
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

2.  Intracranial sinonasal undifferentiated carcinoma (SNUC) in a child.

Authors:  Raj Kumar; Anil Chandra; Archana Rastogi
Journal:  Childs Nerv Syst       Date:  2006-03-23       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.